Augmentiqs

Company Overview

Snapshot

Founded in January 2016 by Gabriel Siegel and Dan Regelman, Augmentiqs operates with 1–10 employees. The company has secured $451.5K across three funding rounds, with Israel Innovation Authority as an investor. In March 2020, Augmentiqs announced a technical partnership and integration with Inspirata, a move that significantly advanced its digital pathology platform.

Business overview

Augmentiqs is a Health Tech & Life Sciences company that develops a digital pathology platform to transform traditional microscopes into smart, connected devices. Its core technology integrates an embedded camera, augmented reality for the eyepiece, and real-time stage activity tracking, enabling multi-directional communication between the microscope and a PC. This allows pathologists to access pathology software directly from within the microscope while maintaining optical quality. The platform supports real-time telepathology, quantitative image analysis, AI training, LIS integration, and workflow tracking, serving hospitals, laboratories, and pharmaceutical companies in the digital healthcare sector.

Strategic signal

In March 2020, Augmentiqs formed a technical partnership and integration with Inspirata, a move that signals strong market validation and strategic alignment within the digital pathology ecosystem. This collaboration enhances Augmentiqs' reach and functionality, demonstrating its platform's interoperability and potential for broader adoption in clinical and research settings, which is crucial for attracting further investment and expanding its market footprint.

Company Intelligence Q&A

What is Augmentiqs' primary focus?

Augmentiqs focuses on transforming traditional microscopes into smart, connected digital pathology platforms, enabling advanced functionalities like augmented reality and real-time data integration for pathologists.

When was Augmentiqs founded and by whom?

Augmentiqs was founded in January 2016 by co-founders Gabriel Siegel and Dan Regelman.

What significant partnership did Augmentiqs announce in 2020?

In March 2020, Augmentiqs announced a new technical partnership and integration with Inspirata, enhancing its digital pathology solution.

How much capital has Augmentiqs raised?

Augmentiqs has raised a total of $451.5K across three funding rounds, with Israel Innovation Authority as an investor.

What kind of technology does Augmentiqs utilize in its platform?

Augmentiqs integrates an embedded camera, augmented reality for the eyepiece, and real-time tracking of stage activity to enable digital pathology capabilities within existing microscopes.